These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
253 related articles for article (PubMed ID: 20726553)
1. A remote arene-binding site on prostate specific membrane antigen revealed by antibody-recruiting small molecules. Zhang AX; Murelli RP; Barinka C; Michel J; Cocleaza A; Jorgensen WL; Lubkowski J; Spiegel DA J Am Chem Soc; 2010 Sep; 132(36):12711-6. PubMed ID: 20726553 [TBL] [Abstract][Full Text] [Related]
2. A new generation of monoclonal and recombinant antibodies against cell-adherent prostate specific membrane antigen for diagnostic and therapeutic targeting of prostate cancer. Elsässer-Beile U; Wolf P; Gierschner D; Bühler P; Schultze-Seemann W; Wetterauer U Prostate; 2006 Sep; 66(13):1359-70. PubMed ID: 16894535 [TBL] [Abstract][Full Text] [Related]
3. More advantages in detecting bone and soft tissue metastases from prostate cancer using Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003 [TBL] [Abstract][Full Text] [Related]
4. Purification of prostate-specific membrane antigen using conformational epitope-specific antibody-affinity chromatography. Liu T; Toriyabe Y; Berkman CE Protein Expr Purif; 2006 Oct; 49(2):251-5. PubMed ID: 16815035 [TBL] [Abstract][Full Text] [Related]
5. Chemical control over immune recognition: a class of antibody-recruiting small molecules that target prostate cancer. Murelli RP; Zhang AX; Michel J; Jorgensen WL; Spiegel DA J Am Chem Soc; 2009 Dec; 131(47):17090-2. PubMed ID: 19888723 [TBL] [Abstract][Full Text] [Related]
6. PSMA specific single chain antibody-mediated targeted knockdown of Notch1 inhibits human prostate cancer cell proliferation and tumor growth. Su Y; Yu L; Liu N; Guo Z; Wang G; Zheng J; Wei M; Wang H; Yang AG; Qin W; Wen W Cancer Lett; 2013 Sep; 338(2):282-91. PubMed ID: 23752065 [TBL] [Abstract][Full Text] [Related]
7. Biorecognition and subcellular trafficking of HPMA copolymer-anti-PSMA antibody conjugates by prostate cancer cells. Liu J; Kopecková P; Bühler P; Wolf P; Pan H; Bauer H; Elsässer-Beile U; Kopecek J Mol Pharm; 2009; 6(3):959-70. PubMed ID: 19344119 [TBL] [Abstract][Full Text] [Related]
8. Mass spectral analyses of labile DOTA-NHS and heterogeneity determination of DOTA or DM1 conjugated anti-PSMA antibody for prostate cancer therapy. Lu SX; Takach EJ; Solomon M; Zhu Q; Law SJ; Hsieh FY J Pharm Sci; 2005 Apr; 94(4):788-97. PubMed ID: 15729708 [TBL] [Abstract][Full Text] [Related]
9. Prostate-Specific Membrane Antigen PET Imaging in Prostate Cancer: Opportunities and Challenges. Oh SW; Cheon GJ Korean J Radiol; 2018; 19(5):819-831. PubMed ID: 30174470 [TBL] [Abstract][Full Text] [Related]
10. Fc-Binding Antibody-Recruiting Molecules Targeting Prostate-Specific Membrane Antigen: Defucosylation of Antibody for Efficacy Improvement*. Sasaki K; Harada M; Yoshikawa T; Tagawa H; Harada Y; Yonemitsu Y; Ryujin T; Kishimura A; Mori T; Katayama Y Chembiochem; 2021 Feb; 22(3):496-500. PubMed ID: 32969164 [TBL] [Abstract][Full Text] [Related]
11. In vitro characterization of radiolabeled monoclonal antibodies specific for the extracellular domain of prostate-specific membrane antigen. Smith-Jones PM; Vallabahajosula S; Goldsmith SJ; Navarro V; Hunter CJ; Bastidas D; Bander NH Cancer Res; 2000 Sep; 60(18):5237-43. PubMed ID: 11016653 [TBL] [Abstract][Full Text] [Related]
12. In vitro affinity maturation of an anti-PSA antibody for prostate cancer diagnostic assay. Muller BH; Savatier A; L'Hostis G; Costa N; Bossus M; Michel S; Ott C; Becquart L; Ruffion A; Stura EA; Ducancel F J Mol Biol; 2011 Dec; 414(4):545-62. PubMed ID: 22019475 [TBL] [Abstract][Full Text] [Related]
13. Targeting prostate cancer: Prostate-specific membrane antigen based diagnosis and therapy. Wüstemann T; Haberkorn U; Babich J; Mier W Med Res Rev; 2019 Jan; 39(1):40-69. PubMed ID: 29771460 [TBL] [Abstract][Full Text] [Related]